Quick Takeaways
- This page summarizes David M. Mott's Form 4 filing for Adaptimmune Therapeutics PLC (ADAP).
- 1 reported transaction and 1 derivative row are listed below.
- Filing timestamp: 01 Jul 2022, 17:00.
David M. Mott - 01 Jul 2022 Form 4 Insider Report for Adaptimmune Therapeutics PLC (ADAP)
- Role
- Director
- Signature
- /s/ David M. Mott
- Issuer symbol
- ADAP
- Transactions as of
- 01 Jul 2022
- Net transactions value
- $0
- Form type
- 4
- Filing time
- 01 Jul 2022, 17:00:27 UTC
- Previous filing
- 05 Jul 2022
- Next filing
- 16 Aug 2022
- SEC
- View on sec.gov
Quoteable Key Fact
"David M. Mott filed Form 4 for Adaptimmune Therapeutics PLC (ADAP) on 01 Jul 2022."
What Changed
- Previous filing in this sequence was filed on 05 Jul 2022.
- Current net transaction value: $0.
Why This Matters
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Official SEC Source
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | ADAP | Option to purchase Ordinary Shares | Award | $0 | +1,000,439 | $0.000000 | 1,000,439 | 01 Jul 2022 | Ordinary Shares | 1,000,439 | $0.2800 | Direct | F1 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Explanation of Responses:
| Id | Content |
|---|---|
| F1 | The exercise price was converted from GBP0.23 based on an exchange rate of $U.S. 1.216007 to GBP1.00. The actual exercise price will be the pounds sterling amount |